『ImmunoCAST』のカバーアート

ImmunoCAST

ImmunoCAST

著者: Thermo Fisher Scientific
無料で聴く

From medical guidelines and best practices to educational insights on specific disease states, ImmunoCAST is a podcast dedicated to providing healthcare providers of all specialties clinically relevant, easy-to-digest episodes on allergy related topics.Copyright 2026 ImmunoCAST 生物科学 科学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • The Microbiome and Allergy: What Primary Care Should Know
    2026/08/25
    About 30% to 40% of the world’s population is affected by some form of allergic disease, making allergy a routine consideration in primary care. But as interest in the microbiome grows, clinicians and patients face an important question: what does the evidence actually tell us about its role in allergic disease? This episode explores immune development, the hygiene and biodiversity hypotheses, food allergy, early-life tolerance, the gut-skin axis, atopic dermatitis, asthma, allergic rhinitis, antibiotic exposure, diagnostic testing, and early peanut introduction. The discussion separates established evidence from emerging associations and considers what, if anything, should change in clinical practice today. Clinicians will come away with practical guidance on maintaining evidence-based allergy diagnosis and management while understanding where microbiome research may shape future approaches to prevention and care. Resources and references: https://www.thermofisher.com/phadia/us/en/resources/immunocast/microbiome-and-allergy-what-primary-care-should-know.html?cid=0ct_3pc_05032024_9SGOV4
    続きを読む 一部表示
    35 分
  • Closing the Lab-to-Clinic Gap in Allergy and Autoimmunity (ft. Dr. Zachary Rubin & Dr. Crista Prates)
    2026/08/05
    Many diagnoses involve laboratory diagnostics, yet patients with autoimmune and allergic disease still face delayed or incomplete testing. In this live recording of ImmunoCAST from Lab Week 2026, featuring allergist Dr. Zachary Rubin and autoimmune specialist Dr. Crista Prates, we examine how laboratories can close the gap with smarter clinician partnerships, reflex and tiered testing, ANA follow-up strategies, anti-CCP and rheumatoid factor interpretation, and comprehensive aeroallergen and food allergy diagnostics. The discussion also covers seronegative disease, spondyloarthritis, chronic sinusitis, allergen component diagnostics, and when sensitization does—or does not—equal clinical allergy. Listeners will gain practical insights to help improve diagnostic accuracy, reduce patient anxiety, and support earlier treatment decisions. References and resources: https://www.thermofisher.com/phadia/us/en/resources/immunocast/labs-to-clinic-closing-autoimmune-allergy-testing-gaps.html?cid=0ct_3pc_05032024_9SGOV4
    続きを読む 一部表示
    30 分
  • Early-Life Allergy Risk, Precision Diagnostics, and the Future of Prevention (ft. Dr. Anna Asarnoj)
    2026/07/21
    A 7% sensitization rate by 3 months of age highlights how early allergic disease can begin, making early recognition critical for long-term patient outcomes. In this episode, internationally recognized allergy researcher and pediatric allergist Dr. Anna Asarnoj shares insights from the landmark BAMSE birth cohort and her decades of research on how allergies develop, evolve, and sometimes resolve over time. Together, we explore the atopic march, early-life sensitization, component-resolved diagnostics, pet allergen risk stratification, oral immunotherapy, and emerging strategies to prevent food allergy before it becomes clinically established. Gain practical, evidence-based insights to improve diagnostic precision, risk assessment, and long-term allergy Resources and references: https://www.thermofisher.com/phadia/us/en/resources/immunocast/early-life-sensitization-food-allergy-risk.html?cid=0ct_3pc_05032024_9SGOV4
    続きを読む 一部表示
    31 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません